These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33638205)

  • 1. The foggy world(s) of p63 isoform regulation in normal cells and cancer.
    Pokorná Z; Vysloužil J; Hrabal V; Vojtěšek B; Coates PJ
    J Pathol; 2021 Jul; 254(4):454-473. PubMed ID: 33638205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
    Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
    Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma.
    Pokorna Z; Hrabal V; Tichy V; Vojtesek B; Coates PJ
    Front Oncol; 2022; 12():924354. PubMed ID: 35912167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses.
    Napoli M; Deshpande AA; Chakravarti D; Rajapakshe K; Gunaratne PH; Coarfa C; Flores ER
    Cancer Res Commun; 2024 Feb; 4(2):264-278. PubMed ID: 38165157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent alteration of p63 expression in human primary bladder carcinomas.
    Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
    Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues.
    Sethi I; Romano RA; Gluck C; Smalley K; Vojtesek B; Buck MJ; Sinha S
    BMC Genomics; 2015 Aug; 16():584. PubMed ID: 26251276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
    PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
    Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
    Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.
    Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ
    Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.
    Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation.
    Wu HH; Wang B; Armstrong SR; Abuetabh Y; Leng S; Roa WHY; Atfi A; Marchese A; Wilson B; Sergi C; Flores ER; Eisenstat DD; Leng RP
    Nucleic Acids Res; 2021 Mar; 49(5):2740-2758. PubMed ID: 33619536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAp63 and DeltaNp63 in cancer and epidermal development.
    Candi E; Dinsdale D; Rufini A; Salomoni P; Knight RA; Mueller M; Krammer PH; Melino G
    Cell Cycle; 2007 Feb; 6(3):274-85. PubMed ID: 17264681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic pathways regulated by p63.
    Candi E; Smirnov A; Panatta E; Lena AM; Novelli F; Mancini M; Viticchiè G; Piro MC; Di Daniele N; Annicchiarico-Petruzzelli M; Melino G
    Biochem Biophys Res Commun; 2017 Jan; 482(3):440-444. PubMed ID: 28212728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
    Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER
    Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma.
    Katoh I; Tsukinoki K; Hata RI; Kurata SI
    Neoplasia; 2023 Nov; 45():100938. PubMed ID: 37778252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
    Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ
    Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63: a crucial player in epithelial stemness regulation.
    Li Y; Giovannini S; Wang T; Fang J; Li P; Shao C; Wang Y; ; Shi Y; Candi E; Melino G; Bernassola F
    Oncogene; 2023 Nov; 42(46):3371-3384. PubMed ID: 37848625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma.
    Pokorna Z; Vyslouzil J; Vojtesek B; Coates PJ
    Cell Mol Biol Lett; 2022 Feb; 27(1):18. PubMed ID: 35196980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity.
    Uchida K; Ross H; Lotan T; Pignon JC; Signoretti S; Epstein JI; Illei PB
    Hum Pathol; 2015 Mar; 46(3):384-9. PubMed ID: 25548110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.